文献速递心脏核医学

PET在动脉粥样硬化评估中的作用:批判性综述

The Role of PET in Evaluating Atherosclerosis: A Critical Review.
PubMed 文献 · Semin Nucl Med · 2018-08-30

动脉粥样硬化是发达国家主要致病和致死原因,CT和MRI等结构成像对早期斑块检测价值有限。过去十年,FDG和NaF PET被用于检测和表征主要冠状动脉斑块,FDG摄取反映斑块炎症,NaF摄取与部位微钙化相关。近期数据显示NaF较FDG-PET评估该年龄相关疾病敏感性更高,NaF检测微钙化可能成为未来首选研究;基于动物和人类数据,整体评估疾病活动可能克服PET物理限制以优化斑块负荷定量,其他示踪剂作用目前有限且近期不太可能发挥作用。

要点

  • FDG PET摄取反映斑块炎症,NaF PET摄取与斑块部位微钙化相关。
  • 近期数据显示NaF较FDG-PET评估动脉粥样硬化敏感性更高。
  • 基于动物和人类数据,整体评估疾病活动可能克服PET物理限制以优化斑块负荷定量。

核心结论

  • NaF检测微钙化可能成为未来评估动脉粥样硬化的首选研究,整体评估疾病活动可能克服PET物理限制以优化斑块负荷定量。

研究设计与样本

  • 综述,回顾过去十年FDG和NaF PET检测和表征主要冠状动脉粥样硬化斑块的研究及动物和人类数据。

主要发现

  • FDG摄取反映斑块炎症,NaF摄取与斑块部位微钙化相关。
  • 近期数据显示NaF较FDG-PET评估该年龄相关疾病敏感性更高。
  • 主要动脉中小体积斑块对疾病过程的最佳可视化和定量构成显著挑战。
  • 基于动物和人类数据,整体评估疾病活动可能克服PET物理限制以优化斑块负荷定量。
  • 其他示踪剂检测动脉粥样硬化的作用目前有限,近期不太可能发挥作用。

关键数值与推荐

  • FDG摄取反映斑块炎症,NaF摄取与斑块部位微钙化相关。
  • 近期数据显示NaF较FDG-PET评估该年龄相关疾病敏感性更高。

临床怎么用

  • FDG和NaF PET可用于检测和表征主要冠状动脉粥样硬化斑块。
  • NaF检测微钙化可能成为未来评估动脉粥样硬化的首选研究。
  • 整体评估疾病活动可能用于优化斑块负荷定量。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Atherosclerosis is a common age-related disorder and is the major cause of morbidity and mortality in the developed countries. Structural imaging techniques, such as CT and MRI, have been of limited value in early detection of atherosclerotic plaques, and therefore, there is a dire need for techniques that are highly sensitive and specific for this purpose. Over the past decade, PET imaging with FDG and NaF has been tested for detection and characterization of atherosclerotic plaques in the major coronary arteries. While FDG uptake reflects inflammation in the plaques, NaF uptake is related to micro-calcification at the site. Recent data have revealed higher sensitivity for NaF compared to that of FDG-PET imaging for assessing this age-related disorder. Therefore, it is conceivable that detection of micro-calcification by NaF may become the study of choice in the future. Also, small volume of plaques even in the major arteries poses a significant challenge for optimal visualization and quantification of the disease process. Based on animal and human data, it has become apparent that global assessment of disease activity may overcome the physical limitations of PET imaging for optimal quantification of plaque burden in the arteries. The role of other tracers for detection of atherosclerosis is limited at this time and it is unlikely that other compounds will play a role in assessing plaques in the near future.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Moghbel M, Al-Zaghal A, Werner TJ, et al. The Role of PET in Evaluating Atherosclerosis: A Critical Review. Semin Nucl Med. 2018. PMID: 30322475. doi:10.1053/j.semnuclmed.2018.07.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。